Dr. Hongshan Li is marketing applications manager of Pall ForteBio and has over 20 years of experiences in cutting edge biotechnology. Mainly focused on genomics , proteomics and other related areas , he had been president of 128CUTE from 2013 to 2015 . Dr. Li has been
manager of QFW consulting , Bio-AAA CEO , Ciphergen business development manager of Northeastern US . He had been Senior Technical advisor of Quanterix , Bioscale and Corning , he has extensive experiences on sequencing tools , mass spectrometry , label-free drug screening tools , cell engineering , single molecule detection platform and other medical equipment . He has published 38 articles . He has one patent on cancer preclinical diagnosis and has been invited to the International Conference as chapter chairman .